[SIGNAL DETECTED]

THE INTERSECTION
OF BIOLOGY AND
VENTURE CAPITAL.

We do not sell anything.

We do not run a clinic.

We aggregate global data to separate 'Silicon Valley Hype' from 'Biological Reality'.

+ Active Trackers:
> PubMed:14,203 Papers
> Crunchbase:812 Startups
> ClinicalTrials.gov:Parsing...
[THE FILTER]

Two Streams. One Mission.

Stream A

THE PROTOCOLS

"How do I live longer?"

> Molecule Analysis
> Intervention Efficacy
> Risk/Reward Ratios
Stream B

THE MARKET

"Where is the money flowing?"

> Startup Scouting
> Venture Capital Flows
> Technology Adoption Curves
[LATEST DISPATCHES]

DEC 2025

[PUBLISHED ON]

All Intelligence on Substack

Subscribe to receive deep dives, market analysis, and biological research directly in your inbox.

[TRUST BUILDER]

OUR FORENSIC METHODOLOGY

We analyse the longevity market like a Hedge Fund analyses a stock.

Step 1

AGGREGATE

(Data Mining)

We gather lots of secondary data and group them.

Step 2

AUDIT

(Conflict Check)

We check funding sources for bias.

Step 3

SYNTHESISE

(The Thesis)

We condense hours of research into a 10 minute PDF.

"Our longevity research is not funded."

[HIGH-VALUE CAPTURE]

SECURE YOUR EDGE.

Access our data as soon as it is published.